MeSH tree: E05.200.875.950
A single 40-mg dose of the antiviral drug suraxavir marboxil significantly shortened flu symptom resolution time in male patients aged 5–65, according to research led by the China-Japan Friendship Hospital in China. Intriguingly, ...
Important differences in how the nasal cells of young and elderly people respond to the SARS-CoV-2 virus, could explain why children typically experience milder COVID-19 symptoms, finds a new study led by researchers at UCL ...
Apr 15, 2024
0
94
With new cases, hospitalizations and mortality rates holding steady in many parts of the world, University of Georgia researchers have developed a faster detection technique for COVID-19.
Apr 4, 2024
0
62
Published in the Journal of Infectious Diseases, new research led by the University of Minnesota Medical School offers a new avenue of hope in the fight against chronic human immunodeficiency virus (HIV) infection.
Feb 14, 2024
0
136
For adults with mild-to-moderate COVID-19, early administration of simnotrelvir plus ritonavir shortens the time to sustained resolution of symptoms, according to a study published in the Jan. 18 issue of the New England ...
Jan 18, 2024
0
29
A novel device developed by researchers from Tokyo Institute of Technology, Tokyo Medical and Dental University, and Chiba University in a new study utilizes ions and an electric field to effectively capture infectious droplets ...
Oct 24, 2023
0
34
New research from The Ohio State University College of Medicine finds COVID-19 vaccine mandates are highly effective at reducing the spread of the virus and increasing immunity in a university setting.
Sep 6, 2023
0
239
A new NIST Standard Reference Material supports the accurate measurement of the amount of a common but potentially dangerous virus in patients.
Jul 20, 2022
0
53
